ANRO•benzinga•
Alto Neuroscience Announces USPTO Granted Patent Covering ALTO-300 For Patients With Major Depressive Disorder Characterized By An Electroencephalogram Biomarker
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on February 19, 2025 by benzinga